$4.66 Billion is the total value of Artal Group S.A.'s 132 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 43.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WW | WW INTL INC | $361,566,000 | +29.3% | 14,818,300 | 0.0% | 7.76% | +14.3% | |
| SEER | New | SEER INC | $327,909,000 | – | 5,840,911 | +100.0% | 7.04% | – |
| BGNE | Buy | BEIGENE LTDsponsored adr | $258,390,000 | +0.2% | 1,000,000 | +11.1% | 5.55% | -11.4% |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $243,430,000 | +180.6% | 71,178,364 | +18.2% | 5.23% | +148.1% |
| XLRN | ACCELERON PHARMA INC | $179,116,000 | +13.7% | 1,400,000 | 0.0% | 3.84% | +0.5% | |
| FATE | Sell | FATE THERAPEUTICS INC | $127,302,000 | +112.3% | 1,400,000 | -6.7% | 2.73% | +87.8% |
| MRTX | MIRATI THERAPEUTICS INC | $109,820,000 | +32.3% | 500,000 | 0.0% | 2.36% | +17.0% | |
| IGMS | Buy | IGM BIOSCIENCES INC | $105,948,000 | +108.4% | 1,200,000 | +74.2% | 2.27% | +84.3% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $103,976,000 | -10.7% | 800,000 | 0.0% | 2.23% | -21.1% | |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $101,913,000 | +130.9% | 2,100,000 | -15.8% | 2.19% | +104.1% |
| GDS | GDS HLDGS LTDsponsored ads | $93,640,000 | +14.4% | 1,000,000 | 0.0% | 2.01% | +1.2% | |
| ALVR | ALLOVIR INC | $89,310,000 | +39.8% | 2,323,371 | 0.0% | 1.92% | +23.6% | |
| ARGX | Sell | ARGENX SEsponsored adr | $88,227,000 | +3.7% | 300,000 | -7.5% | 1.89% | -8.3% |
| ABBV | Buy | ABBVIE INCcall | $85,720,000 | +95.7% | 800,000 | +60.0% | 1.84% | +73.1% |
| BNTX | Sell | BIONTECH SEsponsored ads | $81,520,000 | -32.0% | 1,000,000 | -42.2% | 1.75% | -39.9% |
| GBIO | GENERATION BIO CO | $79,782,000 | -8.3% | 2,814,191 | 0.0% | 1.71% | -18.9% | |
| TGTX | TG THERAPEUTICS INC | $78,030,000 | +94.4% | 1,500,000 | 0.0% | 1.68% | +72.0% | |
| Z | Buy | ZILLOW GROUP INCcl c cap stk | $71,390,000 | +251.4% | 550,000 | +175.0% | 1.53% | +211.0% |
| SDGR | Sell | SCHRODINGER INC | $63,142,000 | +48.1% | 797,445 | -11.1% | 1.36% | +31.0% |
| BMY | New | BRISTOL-MYERS SQUIBB COcall | $62,030,000 | – | 1,000,000 | +100.0% | 1.33% | – |
| BEKE | Buy | KE HLDGS INCsponsored ads | $61,540,000 | +15.4% | 1,000,000 | +14.9% | 1.32% | +2.0% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $57,725,000 | +36.3% | 2,500,000 | -16.7% | 1.24% | +20.5% |
| MORF | MORPHIC HLDG INC | $55,414,000 | +22.7% | 1,651,686 | 0.0% | 1.19% | +8.6% | |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $54,964,000 | +88.5% | 2,800,000 | +24.4% | 1.18% | +66.7% |
| BDTX | Buy | BLACK DIAMOND THERAPEUTICS I | $52,771,000 | +14.7% | 1,646,517 | +8.2% | 1.13% | +1.4% |
| BABA | Sell | ALIBABA GROUP HLDG LTDsponsored ads | $46,546,000 | -62.7% | 200,000 | -52.9% | 1.00% | -67.1% |
| SQZ | New | SQZ BIOTECHNOLOGIES CO | $46,551,000 | – | 1,606,308 | +100.0% | 1.00% | – |
| BABA | New | ALIBABA GROUP HLDG LTDcall | $46,546,000 | – | 200,000 | +100.0% | 1.00% | – |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $42,648,000 | +50.2% | 350,000 | +7.7% | 0.92% | +32.9% |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $41,265,000 | – | 750,000 | +100.0% | 0.89% | – |
| CCXI | New | CHEMOCENTRYX INC | $40,248,000 | – | 650,000 | +100.0% | 0.86% | – |
| KRON | New | KRONOS BIO INC | $39,367,000 | – | 1,317,954 | +100.0% | 0.84% | – |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $37,837,000 | – | 2,282,100 | +100.0% | 0.81% | – |
| ITOS | ITEOS THERAPEUTICS INC | $37,001,000 | +37.1% | 1,094,047 | 0.0% | 0.79% | +21.2% | |
| FHTX | New | FOGHORN THERAPEUTICS INC | $34,879,000 | – | 1,720,720 | +100.0% | 0.75% | – |
| SAGE | Buy | SAGE THERAPEUTICS INC | $34,604,000 | +154.7% | 400,000 | +79.9% | 0.74% | +125.2% |
| IMAB | I MABsponsored ads | $34,184,000 | +0.3% | 725,000 | 0.0% | 0.73% | -11.4% | |
| DNLI | DENALI THERAPEUTICS INC | $33,504,000 | +133.8% | 400,000 | 0.0% | 0.72% | +106.6% | |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $32,634,000 | +140.2% | 450,000 | +57.9% | 0.70% | +112.4% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $31,932,000 | +71.5% | 1,200,000 | +20.0% | 0.69% | +51.8% |
| Buy | TRILLIUM THERAPEUTICS INC | $30,891,000 | +44.9% | 2,100,000 | +40.0% | 0.66% | +28.2% | |
| RUBY | RUBIUS THERAPEUTICS INC | $28,682,000 | +51.5% | 3,778,913 | 0.0% | 0.62% | +33.9% | |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $28,535,000 | -7.3% | 500,000 | -16.7% | 0.61% | -17.9% |
| TSHA | Sell | TAYSHA GENE THERAPIES INC | $27,625,000 | +8.1% | 1,040,882 | -8.8% | 0.59% | -4.4% |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $27,100,000 | +46.2% | 2,500,000 | +38.9% | 0.58% | +29.3% |
| REPL | REPLIMUNE GROUP INC | $26,705,000 | +65.7% | 700,000 | 0.0% | 0.57% | +46.5% | |
| ALBO | Sell | ALBIREO PHARMA INC | $26,257,000 | -7.6% | 700,000 | -17.8% | 0.56% | -18.3% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCcall | $25,994,000 | – | 200,000 | +100.0% | 0.56% | – |
| ALXO | Buy | ALX ONCOLOGY HLDGS INC | $25,860,000 | +585.2% | 300,000 | +200.0% | 0.56% | +503.3% |
| QURE | Sell | UNIQURE NV | $25,291,000 | -8.4% | 700,000 | -6.7% | 0.54% | -19.1% |
| NG | NOVAGOLD RES INC | $25,142,000 | -18.7% | 2,600,000 | 0.0% | 0.54% | -28.0% | |
| FOLD | AMICUS THERAPEUTICS INCcall | $23,090,000 | +63.5% | 1,000,000 | 0.0% | 0.50% | +44.6% | |
| GOSS | GOSSAMER BIO INC | $22,811,000 | -22.1% | 2,358,968 | 0.0% | 0.49% | -31.1% | |
| TBIO | Sell | TRANSLATE BIO INC | $22,116,000 | +16.1% | 1,200,000 | -14.3% | 0.48% | +2.6% |
| AGEN | AGENUS INC | $21,942,000 | -20.5% | 6,900,000 | 0.0% | 0.47% | -29.7% | |
| SLB | New | SCHLUMBERGER LTDcall | $21,830,000 | – | 1,000,000 | +100.0% | 0.47% | – |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $21,333,000 | +42.1% | 300,000 | -25.0% | 0.46% | +25.8% |
| KURA | Buy | KURA ONCOLOGY INC | $19,596,000 | +16.5% | 600,000 | +9.3% | 0.42% | +3.2% |
| RPTX | REPARE THERAPEUTICS INC | $19,551,000 | +11.5% | 570,000 | 0.0% | 0.42% | -1.4% | |
| TECH | BIO-TECHNE CORP | $19,053,000 | +28.2% | 60,000 | 0.0% | 0.41% | +13.3% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $18,560,000 | +40.9% | 400,000 | 0.0% | 0.40% | +24.4% | |
| FMTX | New | FORMA THERAPEUTICS HLDGS INC | $17,450,000 | – | 500,000 | +100.0% | 0.38% | – |
| TCOM | Sell | TRIP COM GROUP LTDads | $16,865,000 | -5.0% | 500,000 | -12.3% | 0.36% | -16.0% |
| RLAY | RELAY THERAPEUTICS INC | $16,624,000 | -2.4% | 400,000 | 0.0% | 0.36% | -13.8% | |
| ZYME | New | ZYMEWORKS INC | $16,541,000 | – | 350,000 | +100.0% | 0.36% | – |
| NBTX | New | NANOBIOTIX SAsponsored ads | $16,500,000 | – | 1,000,000 | +100.0% | 0.35% | – |
| CRDF | CARDIFF ONCOLOGY INC | $16,191,000 | +26.8% | 900,000 | 0.0% | 0.35% | +12.3% | |
| KYMR | KYMERA THERAPEUTICS INC | $15,500,000 | +91.9% | 250,000 | 0.0% | 0.33% | +69.9% | |
| TCRR | TCR2 THERAPEUTICS INC | $15,465,000 | +52.2% | 500,000 | 0.0% | 0.33% | +34.4% | |
| STOK | Sell | STOKE THERAPEUTICS INC | $15,483,000 | +70.8% | 250,000 | -7.7% | 0.33% | +50.9% |
| IQ | New | IQIYI INCsponsored ads | $14,858,000 | – | 850,000 | +100.0% | 0.32% | – |
| FGEN | Buy | FIBROGEN INC | $14,836,000 | -5.1% | 400,000 | +5.3% | 0.32% | -16.1% |
| CRIS | Buy | CURIS INC | $14,781,000 | +799.1% | 1,804,729 | +28.5% | 0.32% | +692.5% |
| BLU | Buy | BELLUS HEALTH INC NEW | $14,535,000 | +1248.3% | 4,750,000 | +900.0% | 0.31% | +1100.0% |
| KRYS | KRYSTAL BIOTECH INC | $14,250,000 | +39.4% | 237,500 | 0.0% | 0.31% | +23.4% | |
| YMAB | Y-MABS THERAPEUTICS INC | $14,112,000 | +29.0% | 285,028 | 0.0% | 0.30% | +13.9% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $13,830,000 | -6.1% | 1,000,000 | 0.0% | 0.30% | -17.0% | |
| SELB | SELECTA BIOSCIENCES INC | $13,635,000 | +22.2% | 4,500,000 | 0.0% | 0.29% | +8.1% | |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $13,600,000 | +260.1% | 250,000 | +31.6% | 0.29% | +217.4% |
| HARP | HARPOON THERAPEUTICS INC | $13,288,000 | -2.2% | 800,000 | 0.0% | 0.28% | -13.6% | |
| SGTX | New | SIGILON THERAPEUTICS INC | $13,256,000 | – | 276,000 | +100.0% | 0.28% | – |
| BMRN | BIOMARIN PHARMACEUTICAL INCcall | $13,154,000 | +15.3% | 150,000 | 0.0% | 0.28% | +1.8% | |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $12,525,000 | – | 260,500 | +100.0% | 0.27% | – |
| DHR | Sell | DANAHER CORPORATION | $11,107,000 | -31.2% | 50,000 | -33.3% | 0.24% | -39.3% |
| IMUX | Sell | IMMUNIC INC | $10,703,000 | -28.0% | 700,000 | -12.5% | 0.23% | -36.3% |
| HOOK | Buy | HOOKIPA PHARMA INC | $10,531,000 | +85.5% | 949,616 | +58.4% | 0.23% | +63.8% |
| CYTK | New | CYTOKINETICS INC | $10,390,000 | – | 500,000 | +100.0% | 0.22% | – |
| SPRO | Sell | SPERO THERAPEUTICS INC | $9,695,000 | +44.8% | 500,000 | -16.7% | 0.21% | +27.6% |
| BRKR | BRUKER CORP | $9,488,000 | +36.2% | 175,275 | 0.0% | 0.20% | +20.7% | |
| APTX | Buy | APTINYX INC | $8,657,000 | +70.5% | 2,502,035 | +66.6% | 0.19% | +51.2% |
| EVLO | Buy | EVELO BIOSCIENCES INC | $8,463,000 | +238.1% | 700,000 | +47.4% | 0.18% | +198.4% |
| APLT | APPLIED THERAPEUTICS INC | $8,364,000 | +6.0% | 380,000 | 0.0% | 0.18% | -6.2% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $8,224,000 | +11.0% | 1,045,000 | 0.0% | 0.18% | -1.7% | |
| SYRS | Buy | SYROS PHARMACEUTICALS INC | $8,138,000 | +97.8% | 750,000 | +61.1% | 0.18% | +75.0% |
| AAL | AMERICAN AIRLS GROUP INCcall | $7,885,000 | +28.3% | 500,000 | 0.0% | 0.17% | +13.4% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $7,472,000 | +43.3% | 593,030 | 0.0% | 0.16% | +26.0% | |
| ARAV | ARAVIVE INC | $7,396,000 | +20.0% | 1,311,291 | 0.0% | 0.16% | +6.0% | |
| MTCR | Sell | METACRINE INC | $7,270,000 | -45.6% | 924,898 | -29.4% | 0.16% | -52.0% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $7,008,000 | – | 400,000 | +100.0% | 0.15% | – |
| YI | Buy | 111 INCads | $6,950,000 | +72.5% | 1,000,000 | +53.8% | 0.15% | +52.0% |
| LPTX | Buy | LEAP THERAPEUTICS INC | $6,750,000 | +20.7% | 3,000,000 | +6.2% | 0.14% | +6.6% |
| DYN | Sell | DYNE THERAPEUTICS INC | $6,300,000 | -15.7% | 300,000 | -18.9% | 0.14% | -25.4% |
| OVID | OVID THERAPEUTICS INC | $5,775,000 | -59.8% | 2,500,000 | 0.0% | 0.12% | -64.4% | |
| CYCN | CYCLERION THERAPEUTICS INC | $5,561,000 | -49.7% | 1,817,584 | 0.0% | 0.12% | -55.6% | |
| MRNA | Sell | MODERNA INC | $5,224,000 | -75.4% | 50,000 | -83.3% | 0.11% | -78.3% |
| ACIU | AC IMMUNE SA | $5,170,000 | +5.9% | 1,000,000 | 0.0% | 0.11% | -5.9% | |
| PRQR | PROQR THERAPEUTICS N V | $5,024,000 | -12.3% | 1,196,218 | 0.0% | 0.11% | -22.3% | |
| CFRX | New | CONTRAFECT CORP | $5,050,000 | – | 1,000,000 | +100.0% | 0.11% | – |
| KNTE | New | KINNATE BIOPHARMA INC | $4,973,000 | – | 125,000 | +100.0% | 0.11% | – |
| MCRB | Sell | SERES THERAPEUTICS INC | $4,900,000 | -42.3% | 200,000 | -33.3% | 0.10% | -49.0% |
| KLDO | KALEIDO BIOSCIENCES INC | $4,555,000 | -17.8% | 500,500 | 0.0% | 0.10% | -27.4% | |
| YMTX | New | YUMANITY THERAPEUTICS INC | $3,696,000 | – | 217,391 | +100.0% | 0.08% | – |
| New | MARINUS PHARMACEUTICALS INC | $3,660,000 | – | 300,000 | +100.0% | 0.08% | – | |
| AXLA | AXCELLA HEALTH INC | $3,698,000 | +12.3% | 712,500 | 0.0% | 0.08% | -1.2% | |
| RNA | AVIDITY BIOSCIENCES INC | $3,637,000 | -9.3% | 142,500 | 0.0% | 0.08% | -19.6% | |
| ORIC | Sell | ORIC PHARMACEUTICALS INC | $3,385,000 | -5.0% | 100,000 | -29.8% | 0.07% | -16.1% |
| ADCT | ADC THERAPEUTICS SA | $3,041,000 | -3.0% | 95,000 | 0.0% | 0.06% | -14.5% | |
| KDNY | New | CHINOOK THERAPEUTICS INC | $2,863,000 | – | 180,500 | +100.0% | 0.06% | – |
| PTGX | PROTAGONIST THERAPEUTICS INC | $2,681,000 | +3.1% | 133,000 | 0.0% | 0.06% | -7.9% | |
| MEIP | MEI PHARMA INC | $2,006,000 | -15.4% | 760,000 | 0.0% | 0.04% | -25.9% | |
| XLE | SELECT SECTOR SPDR TRcall | $1,895,000 | +26.5% | 50,000 | 0.0% | 0.04% | +13.9% | |
| ACET | ADICET BIO INC | $1,817,000 | +18.1% | 129,335 | 0.0% | 0.04% | +5.4% | |
| IDRA | New | IDERA PHARMACEUTICALS INC | $1,835,000 | – | 500,000 | +100.0% | 0.04% | – |
| CHMA | CHIASMA INC | $1,653,000 | +1.2% | 380,000 | 0.0% | 0.04% | -12.5% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $1,518,000 | +5.1% | 351,500 | 0.0% | 0.03% | -5.7% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,258,000 | +26.6% | 110,532 | 0.0% | 0.03% | +12.5% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $1,124,000 | +45.8% | 321,100 | 0.0% | 0.02% | +26.3% | |
| SURF | New | SURFACE ONCOLOGY INC | $924,000 | – | 100,000 | +100.0% | 0.02% | – |
| CEREW | New | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $450,000 | – | 79,600 | +100.0% | 0.01% | – |
| CDTX | CIDARA THERAPEUTICS INC | $449,000 | -29.8% | 224,675 | 0.0% | 0.01% | -37.5% | |
| IDYA | Exit | IDEAYA BIOSCIENCES INC | $0 | – | -8 | -100.0% | 0.00% | – |
| PASG | Exit | PASSAGE BIO INC | $0 | – | -15,648 | -100.0% | -0.01% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -178,600 | -100.0% | -0.03% | – |
| PAND | Exit | PANDION THERAPEUTICS INC | $0 | – | -145,000 | -100.0% | -0.04% | – |
| ADRO | Exit | ADURO BIOTECH INC | $0 | – | -902,500 | -100.0% | -0.05% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -760,000 | -100.0% | -0.06% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -87,400 | -100.0% | -0.07% | – |
| MRUS | Exit | MERUS N V | $0 | – | -250,000 | -100.0% | -0.07% | – |
| PRVL | Exit | PREVAIL THERAPEUTICS INC | $0 | – | -302,750 | -100.0% | -0.08% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCsponsored ads | $0 | – | -285,000 | -100.0% | -0.08% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -1,710,000 | -100.0% | -0.08% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -351,500 | -100.0% | -0.08% | – |
| OXY | Exit | OCCIDENTAL PETE CORP | $0 | – | -375,000 | -100.0% | -0.09% | – |
| AXDX | Exit | ACCELERATE DIAGNOSTICS INC | $0 | – | -427,500 | -100.0% | -0.11% | – |
| ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -100,000 | -100.0% | -0.12% | – |
| VXRT | Exit | VAXART INC | $0 | – | -750,000 | -100.0% | -0.12% | – |
| RGNX | Exit | REGENXBIO INC | $0 | – | -222,300 | -100.0% | -0.15% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.17% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -250,000 | -100.0% | -0.23% | – |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -250,000 | -100.0% | -0.26% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -1,000,000 | -100.0% | -0.29% | – |
| GM | Exit | GENERAL MTRS COcall | $0 | – | -500,000 | -100.0% | -0.36% | – |
| STNE | Exit | STONECO LTD | $0 | – | -400,000 | -100.0% | -0.51% | – |
| C | Exit | CITIGROUP INCcall | $0 | – | -500,000 | -100.0% | -0.52% | – |
| AAPL | Exit | APPLE INCcall | $0 | – | -200,000 | -100.0% | -0.56% | – |
| MS | Exit | MORGAN STANLEYcall | $0 | – | -500,000 | -100.0% | -0.59% | – |
| XLI | Exit | SELECT SECTOR SPDR TRcall | $0 | – | -500,000 | -100.0% | -0.93% | – |
| BAC | Exit | BK OF AMERICA CORPcall | $0 | – | -2,000,000 | -100.0% | -1.17% | – |
| JPM | Exit | JPMORGAN CHASE & COcall | $0 | – | -1,000,000 | -100.0% | -2.34% | – |
| GS | Exit | GOLDMAN SACHS GROUP INCcall | $0 | – | -875,000 | -100.0% | -4.27% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -2,058,000 | -100.0% | -13.88% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.